Larimar Therapeutics (LRMR) Total Debt (QoQ) (2014 - 2020)
Larimar Therapeutics (LRMR) Total Debt (QoQ) (2014 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -20.29% |
| Dec 31, 2019 | -16.74% |
| Sep 30, 2019 | -14.23% |
| Jun 30, 2019 | -12.37% |
| Mar 31, 2019 | -10.93% |
| Dec 31, 2018 | -25.93% |
| Sep 30, 2018 | 10.80% |
| Jun 30, 2018 | -8.22% |
| Mar 31, 2018 | 0.80% |
| Sep 30, 2016 | -39.18% |
| Jun 30, 2016 | -27.54% |
| Mar 31, 2016 | -21.14% |
| Dec 31, 2015 | -17.04% |
| Sep 30, 2015 | -14.20% |
| Jun 30, 2015 | -12.14% |
| Mar 31, 2015 | -10.62% |
| Dec 31, 2014 | -9.41% |
| Sep 30, 2014 | -8.43% |